CCN2-expressing pericytes are required for bleomycin-induced skin scleroderma

被引：0
|
作者：
Liu, Shangxi [1 ,2 ]
Xu Shi-wen [3 ]
Abraham, David J. [3 ]
Leask, Andrew [1 ,2 ]
机构：
[1] Univ Western Ontario, Div Oral Biol, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada
[2] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada
[3] UCL, Ctr Rheumatol, London NW3 2PF, England
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2010年 / 28卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [1] CCN2-EXPRESSING PERICYTES ARE REQUIRED FOR BLEOMYCIN-INDUCED SKIN SCLERODERMA
    Liu, Shangxi
    Xu Shiwen
    Abraham, David
    Leask, Andrew
    [J]. WOUND REPAIR AND REGENERATION, 2010, 18 (06) : A87 - A87
  • [2] CCN2-expressing pericytes are required for skin fibrosis
    Liu, Shangxi
    Abraham, David J.
    Leask, Andrew
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S69 - S69
  • [3] CCN1 EXPRESSION BY FIBROBLASTS IS REQUIRED FOR BLEOMYCIN-INDUCED SKIN SCLERODERMA
    Thompson, Katherine
    Leask, Andrew
    [J]. RHEUMATOLOGY, 2015, 54 : 142 - 143
  • [4] CCN2 Is Required for Bleomycin-Induced Skin Fibrosis in Mice
    Liu, Shangxi
    Xu Shi-wen
    Abraham, David J.
    Leask, Andrew
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (01): : 239 - 246
  • [5] BLEOMYCIN-INDUCED SCLERODERMA
    FINCH, WR
    RODNAN, GP
    BUCKINGHAM, RB
    PRINCE, RK
    WINKELSTEIN, A
    [J]. JOURNAL OF RHEUMATOLOGY, 1980, 7 (05) : 651 - 659
  • [6] Case of bleomycin-induced scleroderma
    Inaoki, Makoto
    Kawabata, Chiho
    Nishijima, Chihiro
    Yoshio, Nobuyuki
    Kita, Toshiyuki
    [J]. JOURNAL OF DERMATOLOGY, 2012, 39 (05): : 482 - 484
  • [7] Connective tissue growth factor is induced in bleomycin-induced skin scleroderma
    Liu, Shangxi
    Taghavi, Reza
    Leask, Andrew
    [J]. JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2010, 4 (01) : 25 - 30
  • [8] Connective tissue growth factor is induced in bleomycin-induced skin scleroderma
    Shangxi Liu
    Reza Taghavi
    Andrew Leask
    [J]. Journal of Cell Communication and Signaling, 2010, 4 : 25 - 30
  • [9] Vascular Changes in Bleomycin-Induced Scleroderma
    Yamamoto, Toshiyuki
    Katayama, Ichiro
    [J]. INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2011, 2011
  • [10] A novel treatment for scleroderma fibrosis: The CCN3-based peptide BLR-200 impairs bleomycin-induced skin fibrosis
    Peidl, Alex
    Nguyen, John
    Aslam, M. Nadeem
    Varani, James
    Carter, David
    Riser, Bruce L.
    Leask, Andrew
    [J]. WOUND REPAIR AND REGENERATION, 2022, 30 (05) : A11 - A11
12345